Skip to main content
Equibles
DMII logo

DMII · Drugs Made In America Acquisition II Corp. · Analyst Estimates

Track DMII — free

Use DMII with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research DMII.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$10.20 +0.01 (+0.05%) At close · Oct 26
Rebalance outlook locked
Going-concern doubt — flagged Aug 14, 2026

Substantial doubt about the company's ability to continue as a going concern.

“management has determined that these conditions raise substantial doubt about the Company's ability to continue as a going concern within one year after the date that the financial statements are issued. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.”
View the 10-Q filed Aug 14, 2026
Market Cap
$649.42M
Shares
63.70M
Volume · Oct 26 188.03K Avg daily vol (3M) 132.67K

Analyst Estimates

Compare analyst forecasts for Drugs Made In America Acquisition II Corp. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

This verified capture contains no analyst forecast observations. Older snapshots remain in the history.

Captured 2026-09-18 02:58 UTC · Publication dates shown per estimate · 0 metric / period groups

Key facts CIK 2040475 CUSIP G2851K104 13F (30d) 3 filings 3 filers